Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2006-11-14
2006-11-14
Johannsen, Diana B. (Department: 1634)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S091200, C435S233000, C536S023200, C536S023700, C536S024320, C536S024330
Reexamination Certificate
active
07135283
ABSTRACT:
Novel polymorphisms of prokaryotic topoisomerase type II Gyr A, Gyr B and parC gene loci are provided. These polymorphisms differentiate very closely related organisms and provide a means to identify pathogenicity and drug resistance. For example, drug resistance such as resistance to methicillin, a drug which is not metabolically tied to topoisomerase function, may be determined by polymorphisms in the Gyrase A locus. Identification of such drug resistance by such unrelated loci is indicative of heretofore unrecognized [sub]species ofStaphylococcus aureus.
REFERENCES:
patent: 4787963 (1988-11-01), MacConnell
patent: 5445934 (1995-08-01), Fodor et al.
patent: 5527670 (1996-06-01), Stanley
patent: 5605662 (1997-02-01), Heller et al.
patent: 5632957 (1997-05-01), Heller et al.
patent: 5645994 (1997-07-01), Huang
patent: 5648482 (1997-07-01), Meyer
patent: 5653939 (1997-08-01), Hollis et al.
patent: 5849486 (1998-12-01), Heller et al.
patent: 6015666 (2000-01-01), Springer et al.
patent: 6017696 (2000-01-01), Heller
patent: 6048690 (2000-04-01), Heller et al.
patent: 6051380 (2000-04-01), Sosnowski et al.
patent: 6054270 (2000-04-01), Southern
James P. Nataro & James B. Kaper; “DiarrheagenicEscherichia coli”; (Jan. 1998) vol. 11 No. 1, pp. 142-209;Clinical Microbiology Reviews.
K. L. MacDonald & M.T. Osterholm; “The Emergency ofEscherichia coli0157:H7 Infection in the United States: The Changing Epidemiology of Foodborne Disease”; (May 5, 1993) vol. 269 No. 17; pp. 2264-2267;The Journal of the American Medical Association.
Jesse Majkowski; “Strategies for Rapid Response to Emerging Foodborne Microbial Hazards”; (Oct.-Dec. 1997) vol. 3 No. 4; pp. 551-554;Emerging Infectious Diseases.
Bala Swaminathan & Peter Feng; “Rapid Detection of Food-Borne Pathogenic Bacteria”; (1994) vol. 48; pp. 401-426;Annual Review of Microbiology.
Robert D. Arbeit; “Laboratory Procedures for the Epidemiologic Analysis of Microorganisms”; pp. 190-208;Manual of Clinical Microbilogy.
A. Christian Whelen & David H. Persing; “The Role of Nucleic Acid Amplification and Detection in the Clinical Microbiology Laboratory”; (1996) vol. 50; pp. 349-373;Annual Review of Microbiology.
William G. Weisburg, Susan M. Barns, Dale A. Pelletier & David J. Lane; “16S Robosomal DNA Amplification for Phylogenetic Study”; (Jan. 1991) vol. 173 No. 2; pp. 697-703;Journal of Bacteriology.
Jean-Marc Neefs, Yves Van de Peer, Peter De Rijk, Sabine Chapelle & Ruprt De Wachter; “Compilation of Small Ribosomal Subunit RNA Structures”; (Jul. 1, 1993) vol. 21 No. 13; pp. 3025-3049;Nucleic Acids Research.
Wai Mun Huang; “Bacterial Diversity Based On Type II DNA Topoisomerase Genes”; (1996) vol. 30 pp. 79-107;Annual Review of Genetics.
Isabelle Guillemin, Emmanuelle Cambau & Vincent Jarlier; “Sequences of Conserved Region in the A Subunit of DNA Gyrase from Nine Species of the Genus Mycobacterium: Phylogenetic Analysis and Implication for Intrinsic Susceptibility to Quinolones”; (Sep. 1995) vol. 39 No. 9; pp. 2145-2149;Antimicrobial Agents&Chemotherapy.
Gary J. Olsen, Carl R. Woese & Ross Overbeek; “Minireview”; (Jan. 1994) vol. 176 No. 1; pp. 1-6;Journal of Bacteriology.
Loreen A. Herwaldt & Richard P. Wenzel; “Dynamics of Hospital-Acquired Infection”; Sixth Edition; pp. 159-181;Manual of Clinical Microbiology.
Margaret M. Morita, BA, CIC; “Methicillin-ResistantStaphylococcus aureusPast, Present & Future”; (Sep. 1993) vol. 28 No. 3; pp. 625-637;The Nursing Clinics of North America.
Gordon L. Archer & Debra M. Niemeyer; “Origin and Evolution of DNA Associated With Resistance to Methicillin in Staphylococci”; (1994) vol. 2;Trends in Microbiology Virulence, Infection and Pathogenesis.
Kazuhisa Murakami, Wakio Minamide, Koji Wada, Etuo Nakamura, Hiroshi Teraoka & Sachihiko Watanabe; Identification of Methicillin-Resistant Strains of Staphylococci by Polymerase Chain Reaction; (Oct. 1991) vol. 29 No. 10; pp. 2240-2244;Journal of Clinical Microbiology.
Shangwei Wu, Claudia Piscitelli, Herminia de Lencastre & Alexander Tomasz; “Tracking the Evolutionary Origin of the Methicillin Resistance Gene: Cloning and Sequencing of a Homologue of mecA from a Methicillin Susceptible Strain ofStaphylococcus sciuri”; (1996) vol. 2 No. 4; pp. 435-441;Microbial Drug Resistance.
Matthias, Husmann, Alix Feddersen, Annette Steitz, Claudia Freytag & Sucharit Bhardi; “Simultaneous Identification of Campylabacters and Prediction of Quinolone Resistance by Comparative Sequence Analysis”; (Sep. 1997) vol. 35 No. 9; pp. 2398-2400;Journal of Clinical Microbiology.
Tong Wang, Mayumi Tanaka & Kenichi Sato; “Detection of grlA and gyrA Mutations in 344Staphylococcus aureusStrains”; (Feb. 1998) vol. 42 No. 2; pp. 236-240;Antimicrobial Agents&Chemotherapy.
Mehta Prashant
Nerenberg Michael
Radtkey Ray
Vollmer Dana
Johannsen Diana B.
Nanogen Inc.
O'Melveny & Myers LLP
LandOfFree
Topoisomerase type II gene polymorphisms and their use in... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Topoisomerase type II gene polymorphisms and their use in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Topoisomerase type II gene polymorphisms and their use in... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3652287